Journal profile · PHARMACOLOGY & PHARMACY
Saudi Pharmaceutical Journal
ISSN 1319-0164 · King Saud University · SAUDI ARABIA · Founded 1993
Saudi Pharmaceutical Journal: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 4.24; fully open access; APC about USD 2,790; median 97 days to acceptance (75 articles, last 24 months); community-reported acceptance: easy; 54 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Saudi Pharmaceutical Journal is published by King Saud University and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Pharmaceutical Practices and Patient Outcomes, Advanced Drug Delivery Systems and Drug Solubulity and Delivery Systems, together about 26.2% of its articles. Its main subfields are Pharmaceutical Science. (generated from OpenAlex topic counts and CAS ranking data)
Read the latest articles of Saudi Pharmaceutical Journal at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature
From the journal's Aims & Scope
Research area (LetPub): PHARMACOLOGY & PHARMACY
Main research topics OpenAlex counts of recent articles; shares are approximate
- Pharmaceutical Practices and Patient OutcomesMedicine11.3%
- Advanced Drug Delivery SystemsPharmacology, Toxicology and Pharmaceutics7.7%
- Drug Solubulity and Delivery SystemsPharmacology, Toxicology and Pharmaceutics7.2%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance5.5%
- Human auditory perception and evaluationEngineering5.5%
- Diverse Specialized Academic ResearchEconomics, Econometrics and Finance4.9%
- Pharmacovigilance and Adverse Drug ReactionsPharmacology, Toxicology and Pharmaceutics4%
- Essential Oils and Antimicrobial ActivityAgricultural and Biological Sciences3.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.24LetPub ·
- CiteScore 2026-06
- 8.2LetPub ·
- SJR 2026-06
- 0.76LetPub ·
- SNIP 2026-06
- 1.16LetPub ·
- h-index
- 36LetPub ·
- h-index
- 105OpenAlex ·
- i10-index
- 1,403OpenAlex ·
- 2-year mean citedness
- 6.28OpenAlex ·
- Self-citation rate
- 2.3%LetPub ·
- Share of gold OA articles
- 99.48%LetPub ·
Volume
- Articles per year
- 54LetPub ·
Articles by year OpenAlex count · 2,325 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 59 | 59 | 44 |
| 2025 | 54 | 54 | 210 |
| 2024 | 184 | 184 | 1,611 |
| 2023 | 347 | 347 | 4,229 |
| 2022 | 216 | 216 | 3,370 |
| 2021 | 182 | 182 | 4,011 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
97 daysMedian, submission to acceptance · P25–P75 76 days – 137 days
- Acceptance to online
- median 48 days (75 articles)
- Submission to online
- median 162 days
- Sample
- 75 articles with submission and acceptance dates (152 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to publication (journal-reported)
- about 12 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 2,390 / USD 2,790 / GBP 2,090 | Yes | CC BY, CC BY-NC-ND | |
| OpenAlex | USD 2,690 / EUR 2,290 / GBP 1,990 | — | — | |
| LetPub | USD 1,450 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- King Saud University
- Country or region
- SAUDI ARABIA
- Language
- English
- Founded
- 1993
- ISSN
- 1319-0164
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗LetPub
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Saudi Pharmaceutical Journal
What CAS zone is Saudi Pharmaceutical Journal in?
In the 2025 upgraded edition of the CAS Journal Ranking, Saudi Pharmaceutical Journal is in Zone 3 of Medicine, and in Zone 3 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Saudi Pharmaceutical Journal?
The latest impact factor listed by LetPub is 4.24; CiteScore 8.2, h-index 105.
How long does peer review take at Saudi Pharmaceutical Journal?
Based on the dates recorded on 75 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 97 days (interquartile range 76–137 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Saudi Pharmaceutical Journal?
According to LetPub and DOAJ records, Saudi Pharmaceutical Journal is indexed in SCIE, Scopus and DOAJ.
Is Saudi Pharmaceutical Journal open access, and what is the APC?
Saudi Pharmaceutical Journal is a fully open-access journal. APC about USD 2,790.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .